Publication | Open Access
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
415
Citations
16
References
2022
Year
ClinicalTrials.gov Identifier: NCT04063163.
| Year | Citations | |
|---|---|---|
Page 1
Page 1